Metaphore Biotechnologies Funding & Investors
Cambridge, MA
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.
metaphorebio.comTotal Amount Raised: $50,000,000
Metaphore Biotechnologies Funding Rounds
Undisclosed
$50,000,000
Undisclosed Investors
Flagship Pioneering
Funding info provided by Diffbot.